key: cord-0060011-2tak2nbn
authors: Mohanrasu, K.; Rao, R. Guru Raj; Sudhakar, M.; Raja, Rathinam; Jeyakanthan, J.; Arun, A.
title: Marine Microbial Pharmacognosy: Prospects and Perspectives
date: 2020-06-30
journal: Marine Niche: Applications in Pharmaceutical Sciences
DOI: 10.1007/978-981-15-5017-1_5
sha: 28ac3918ce1d9e682454b252796502750c1fa67d
doc_id: 60011
cord_uid: 2tak2nbn

Modern scientific advancements and research on marine microbes has revealed their significance as producers of therapeutic products useful in treating various human diseases. Microbes in marine habitat have evolved to adapt to the harsh condition that prevails in the ocean. Their struggle to compete for space and nutrients has paved way for the synthesis of different novel enzymes possessing distinctive characteristics. Thus, marine habitat hosts many remarkable microorganisms that offer unique biologically active compounds, enzymes endowed with astonishing properties, and mechanism to survive in extreme environmental conditions. The utilization of marine biotic resources grows at an extraordinary growth rate of 12% per annum and is evident from about 4900 patents filed connected with marine genetic resources and 18,000 natural compounds. This concern has boosted research all over the world to explore the untapped potential hidden in marine microbes, which has lot of biotechnological applications that includes bioactive compounds (metabolites) for therapeutics, novel enzymes, cosmetics, and nutraceuticals. This book chapter will meticulously deliberate the utilization of marine resources by biotechnological applications for therapeutics like antibiotics, chemical compounds, biopolymer, enzymes, and various microbial biomedical purposes such as drug delivery and tissue engineering from marine biota (bacteria, fungi, and algae).

The ocean engulfs about 70% of the area on planet earth whereas the aquatic ecosystem houses nearly 80% of living organisms on the whole biosphere. The marine environment hosts 178,000 different species of microorganisms (34 phyla) as reported by the United Nations Environment Programme on Global Biodiversity Assessment (UEPA 2006) . The marine unicellular organisms play a crucial role in the conservation and sustainability of the marine ecosystem. The marine microbes are competent in enduring from volcanic eruptions to Antarctic glacier, and they possess numerous distinctive adaptations compared to the terrestrial microbes. Marine microbes adapt to environmental variations like high salt concentration, extreme temperature, low or higher concentrations of organic matter, high hydrostatic pressure, and other external physiochemical factors. Due to their continued exposure to various environmental changes, they have developed unique defense and survival mechanisms employing secondary metabolites that can sense, adopt, and protect them from such harsh conditions.

Microbes are the modern day marvel, whose potential has not been fully explored, yet they offer extensive application in diverse fields like heavy metal bioremediation (Rainbow 1995) , antibiotics and enzyme production (Okami 1986) , biodegradation and bioremediation of hydrocarbons (Mohanrasu et al. 2018) , biosurfactant production (Maneerat and Phetrong 2007) , degradation of plastic debris (Mohanrasu et al. 2018) , anti-biofilm activity (Jiang et al. 2011) , and polyhydroxybutyrate (bioplastics) synthesis (Arun et al. 2006) . Recently, researchers have discovered a number of novel metabolites from marine bioresources including macro or micro algae, bacteria, and fungi that are used as antimicrobial, anti-obesity, antitumorous, antidiabetic, immunological, and therapeutic potential biomolecules. For example, the Pseudomonas genus serves as a wellspring of bioactive compounds such as andrimid, bushrin, moiramides, phthalate, pseudopeptide, phloroglucinol, phenazine, pyrroles, pyrrolidinedione, phenanthrene, quinolone, and zafrin for the treatment of many diseases (Romanenko et al. 2008) .

The marine microbial biosphere delivers a variety of biomolecules that cater diverse novel biologically active compounds for pharmaceutical applications. This chapter exclusively focuses on biologically active compounds synthesized by marine microbes for pharmaceutical applications; we highlight the varieties of biological compounds from marine-based algae, bacteria, and fungi (Fig. 5 .1 and Table 5 .1).

In today's modern world, with increasing population and demanding food industry, marine habitat acts as a crucial food source that caters around 90 million tons of food per year. Due to the huge biodiversity, marine environment offers a variety of biologically active compounds that could be efficiently employed to treat new diseases. Emerging infectious diseases with newly emerging drug-resistant microbial strains demand pristine compounds that would be tailored by marine microbes as researchers have shifted their interest toward the quest for bioactives from marine sources. Though terrestrial plants and microbes have severed as an important source in last couple of decades for biomedical drug discovery and health, the untapped potentials of marine microbes have emerged as widespread resources. 1940s penicillin was discovered by Alexander Fleming whereas the in same decade penicillinase (resistant to penicillin antibiotic) produced by Staphylococcus aureus was reported similarly in 1950 S. aureus was also found to have developed multi resistant strain to various antibiotics such as tetracycline, aminoglycoside, macrolides, and minoglycoside (López et al. 2018) . To counter this drug resistance, modern pharmaceutical industry has ventured the use of marine environments to foster the next generation of antibiotics. Scientists have isolated in the 1950s the first marine bioactive compounds (spongouridine and spongothymidine) from Cryptotheca crypta (Caribbean sponge) and demonstrated its significant anti-cancer and antiviral properties (Leary et al. 2009 ). Since, the discovery of marine bioactive metabolites, several interesting molecules were isolated from marine environment, which was evident from accelerated research that resulted in a diverse array of applications like pharmacology, biology, biochemistry, organic chemistry, and ecology (Leary et al. 2009 ). The marine diversity has immense untapped potential, awaits for researchers to unravels it, recently more than 1277 new compounds has been published in 432 papers during 2016 alone and a peak 17% rise in research output during 2018 compared to latter 1490 novel compounds from 477 papers (Blunt et al. 2018) . The enormous evolution of technologies in the field of marine biotechnology leads to tremendous therapeutic potent compound breakthroughs from the marine ecosystem. Scientists have found numerous deleterious components possess astonishing therapeutic novel value compounds that are castoff as predator defense mechanisms by marine microbes. Many marine microorganisms have been rigorously investigated over the past 50 years from which 270,000 natural products and 30,000 compounds have been isolated among which 9 compounds have been approved as medical drugs (Blunt et al. 2011; Gerwick and Moore 2012; Rangel and Falkenberg 2015) .

Humans had utilized algae mainly for nutrients (protein) produced by Spirulina (Chlorophyta). Marine microalgae are mainly classified into three types based on the pigmentation as red (Khan et al. 2015) . With the development of improved technologies, a diverse array of application for algae has been recognized from health care, cosmetics, and pharmaceutical. Polyunsaturated fatty acids (PUFAs) from microalgae have started gaining commercial value (Roy and Pal 2015) . There are several compounds isolated from algae that are promising bio alternatives to the existing drug, which exhibits higher efficacy, with nearly less side-effects, and some of them are briefly discussed. The primary producers of marine algae n-3 PUFA have several health benefits such as in treating cardiovascular diseases, brain development, function and as healing for inflammatory conditions. Awad (2000) segregated 3-0-β-D-glucopyranosyl stigmasta-5,25-diene compound from green alga Ulva lactuca, which have potential anti-inflammatory activity. The bioactive compound, Isorawsonol have been isolated by Chen et al. (1994) from tropical green alga Arrainvill arawsonii that exhibited potential anticancer and immunosuppressive effects (Chen et al. 1994) . Cycloeudesmol isolated from marine alga Chondria oppositiclada exhibited potent antibiotic activity against Staphylococcus aureus (Fenical and Sims 1974) . Ascosalipyrrolidinones A and B isolated from green alga Ulva spp. presented potential antiplasmodial activity against Plasmodium falciparum strains NF-54 and Kl (Osterhage et al. 2000) . Halitunal compound isolated from Halimeda tuna displays antiviral toward murine coronavirus A59 in in vitro condition (Koehn et al. 1991) . Two new compounds, Capisterones A and B, are triterpene sulfate esters isolated from green alga Penicillus capitatus, which shows antifungal activity against marine algal pathogen Lindra thallasiae (Puglisi et al. 2004) .

The brown algae color is mainly due to the presence of xanthophyll and fucoxanthin pigments, which mask the presence of other pigments (chlorophyll a and c, β carotenes). Currently there are 1200 compounds reported from brown algae (Phaeophyceae). Leptosins K, K1, and K2 compounds from Sargassum tortile exhibited antitumor activity against sarcoma 180 as cites and cytotoxicity against cultured P388 cells (Takahashi et al. 1995) . The compound Stypoldione from Stypopodium zonale brown alga is found to possess ichthyotoxic effect (Gerwicket al. 1979) . Cis-dihydroxy tetra hydrofuran isolated from brown alga Notheia anomala found in southern coast of Australia showed nematocidal activity against parasitic nematodes such as Trichostrongylu scolubriformis and Haemonchus contortus (Capon et al. 1998 ). Lobophorolide isolated from brown alga Lobophora variegate possesses potent anti-fungal activity against C. albicans and is highly specific against Dendroyphiella salina and Lindra thalassiae (Kubanek et al. 2003) .

Lopophorins A and B compounds from brown alga Lobophora variegate compound illustrated good anti-inflammatory activity (Jiang et al. 1999) . Dictyota pfaffi isolated compound displayed strong anti-human syncytial virus (HSV)-1 activity and moderate activity against human immunodeficiency virus (HIV)-1 reverse transcriptase (Pereira et al. 2004) ; Dictyota dichotoma obtained compounds such as diterpenes, dictyolactone, and sanadaol that showed algicidal activity against dinoflagellate Alexandrium catanella (Finer et al. 1979) ; Ecklonia cava derived 8,8 00 -bieckol (Fukuyama et al. 1989) ; and 8,4 00 -bieckol showed activity against HIV-I and fucosterol from Pelvetia siliquosa that displayed antidiabetic activity (Lee et al. 2004) .

In red algae, the presence of pigments phycoerythrin and phycocyanin are responsible for red coloration, whereas those compounds suppress other pigments xanthophylls, βcarotene, and chlorophyll a and thus are termed as red algae (Bold and Wynne 1985) . The red algae Portieria hornemanii produced halmon (polyhalogenated monoterpene) and showed antitumor activity in in vitro condition (Fuller et al. 1992 ). The red algae Gigartina tenella compounds Sulquinovosyl diacylglycerol, sulfolipid KM043, and KM043 are a class of 6-sulf-α-D-quinovopyranosyl-(l ! 3_)-1,2 diacylglycerol (SQDG) compounds and have potential antiviral activity against HIV-l reverse transcriptase (Ohata et al. 1998 ). Chondriamide C and 3-indol acrylamide were isolated from red algae Chondria atropurpurea and displayed anthelmintic activity toward Nippostrongylus brasiliensis (Davyt et al. 1998) . Vidalols A and B were isolated from red alga Vidalia obtusaloba shown DPPH radical scavenging activity (Choi et al. 2000) .

The red alga Symphyocladia latiussula produce cyclohexanone shown free radical scavenging activity (Choi et al. 2000) . Digenea simplex derived amino acid (αalkokainic acid) shown potent neurophysiological activity in mammals (Biscoe et al. 1975; Ferkany and Coyle 1985) . Laurancia pinnata synthesized compound Laurepinacine and isolaurepinnacin showed insecticidal activity (Fukuzawa and Masamune 1981) . Laurencia brongniarti derived four polybrominated indoles has a potential antimicrobial activity against Saccharomyces cerevisiae and Bacillus subtilis (Carter et al. 1978) . Tichocarpus crinitus red algae obtained tichocarpols A and B showed antifeedant activity against Strongylocentrotus intermedius (Ishii et al. 2004) .

Fucoxanthin is a member of carotenoid present in various species of brown algae exhibited different pharmaceutical applications such as antioxidant activity, anticancer, anti-inflammatory, antiobesity, neuroprotective effect, antiangiogenic, and skin protective effect (Kim and Pangestuti 2011) . The marine algae-derived sulfated polysaccharides are the source for numerous health beneficial activities such as antioxidant, anticoagulant, anti-allergic, anti-human immunodeficiency virus, immunomodulating activities, and anticancer activities (Ngo and Kim 2013) .

Ever since the inception of mankind, nature has been nourishing us with valuable resources for the sustainability of humans by providing necessity for survival like food, shelter, and protection. Extensive screening of marine actinobacteria was started from early 1969 to formulate antagonistic compounds (Weyland 1969 (Solanki et al. 2008) . Marine actinobacteria are the main source for novel secondary metabolites, around the 1970s there were only 11 genera of actinomycetes reported and then in 2005 the number rose to 100 whereas in 2010 the numbers doubled to around 220. The reason behind such a sharp increase in genera is the advancements in sequencing techniques that revealed novel actinomycetes (Subramani and Aalbersberg 2013) . Actinobacteria are filamentous, Gram-positive bacteria belonging to the Actinomycetaceae family. Streptomyces are known for their unsurpassed amount of secondary metabolite productions that account for 80% actinobacterial natural products (Manivasagan et al. 2014a, b) . The marine actinobacteria are found in diverse biological sources (seawater and sediment, sponges, seaweeds, fish, mollusks, and mangroves) and several reports indicated that marine actinobacteria have several biotechnological applications such as antitumor agents, antibiotics, enzyme, immunosuppressive agents, and pigments (Fenical and Jensen 2006; Bull and Stach 2007; Dharmaraj 2010; Mayer et al. 2011) .

The extensive search of bioactive compounds from microorganisms has led to the discovery of 23,000 antibiotics, and several reports have been published related to marine actinobacteria that are biologically active molecules (Lam 2006; Solanki et al. 2008; Zotchev 2012; Manivasagan et al. 2014a, b; Subramani and Sipkema 2019) Apparently, only minor fraction of marine actinomycetes natural products were discovered, but with recent sophisticated techniques made accessibility for isolation and identification of numerous bioactive compounds, which are in pipelines for antimicrobial, anticancer, anti-inflammatory and neuromodulating drugs.

Typically, antibacterial activity implies any element that kills the bacteria or inhibits bacterial growth or it will help to inhibit or kill the infectious diseases causing antibiotic-resistant microorganisms. Riedlinger et al. (2004) isolated novel polycyclic polyketide (Abyssomicin C) antibiotic form Verrucosispora sp., a potent inhibitor of p-aminobenzoic acid biosynthesis that will lead to inhibition of folic acid biosynthesis, an earlier stage inhibition than the well-known synthetic sulfa drugs. Abyssomicin C has potential antibacterial activity against vancomycin-resistant, against Gram-positive bacteria and multi-drug resistant Staphylococcus aureus. A novel compound, bonactin displays antimicrobial activity against both Grampositive and Gram-negative bacteria that are obtained from the liquid culture of Streptomyces sp. BD21-2, the culture was accumulated from Kailua Beach, Oahu, Hawaii (Schumacher et al. 2003) .

El Caboxamycin is a new antibiotic (benzoxazole) produced by Streptomyces sp., are isolated from deep-sea sediments of Canary Basin has inhibitory activity against Gram-positive bacteria (Hohmann et al. 2009a, b, c) .

Several unique structural features of bioactive compounds were obtained from a variety of marine actinomycetes, yet research is conducted to find the novel antibiotics against pathogenic fungi (Subramani and Sipkema 2019) . The common saprophytic nature Streptomyces species are significant to produce complex antibiotics and biopolymers (Wanner 2009 ). In south China, the sponge (Craniella australiensis) associated Marine Streptomyces sp. DA11 was found to produce chitinase enzyme that exhibited antifungal activities against Candida albicans and Aspergillus niger (Han et al. 2009 ).

Daryamides are a novel antifungal compound isolated from marine sediment Streptomyces strain, CNQ-085, that shows antifungal activities against Candida albicans with moderate or weak cytotoxicity against human colon carcinoma cell line HCT-116 (Asolkar et al. 2008) . The antibiotic N-(2-hydroxyphenyl)-2phenazinamine (NHP) was obtained from Nocardia dassonvillei, which has antifungal activity against C. albicans (Gao et al. 2012) . Numerous compounds revealed antifungal activity such as Trioxacarcins, Bonactin, Aureoverticillactam, Rapamycin, FK520 Ascomycin, and Jinggangmycin against some clinically important pathogens like Aspergillus flavus, Trichoderma ressei, C. albicans, Aspergillus niger, and Alternaria alternate.

In recent years, cancer has been the second leading disease with high fatality of about 9.6 million death in 2018. Thus a huge urge for anticancer compounds have raised, result in diverse avenue of researchers extending further pursuit in finding novel anticancer compounds from actinobacteria. Cancer is one of the leading human health problems, breast cancer is responsible for second most causes of deaths in women (Ravikumar et al. 2010) . Several therapeutic treatments are available to counter cancer, which includes immunotherapy, radiotherapy, and chemotherapy even though cancer could not be defeated till date as a major issue for mankind (Gillet et al. 2007) . Salinosporamide A has shown inhibitory effects against various malignant cell types that were isolated from Salinispora tropica in oceanic sediments (Prudhomme et al. 2008) . Salinosporamide A is a proteasome inhibitor which leads to apoptosis in multiple myeloma cells, subsequently entered to phase I of human trials for solid tumors, multiple myeloma and lymphoma Feling et al. 2003) . Stritzke et al. (2004) isolated Streptomyces sp. B6007 from mangrove sediment in Papua New Guinea, acquired caprolactones, which showed moderate cytotoxicity and low cytotoxicity against cancer cells. Miller et al. (2007) isolated Streptomyces sp. CNQ-593 from marine sediments in Guam, and piperazimycins A-C (cyclic hexadepsipeptides) were extracted from the fermentation broth of a Streptomyces sp. with cytotoxic activities against the human colon carcinoma HCT-116 cell line with cytotoxicity of GI50 of 76 ng/mL for each. Piperazimycin A also exhibits potent vitro biological activity against multiple (60) cancer cell lines. Nocardiopsis lucentensis strain CNR-712 produced 

Salinosporamide A has shown potential cytotoxicity against HCT-116 human colon carcinoma, MDA-MB-435 breast cancer, SF-539 CNS cancer, NCI-H226 non-small cell lung cancer, and SK-MEL-28 melanoma cells (Feling et al. 2003) . Two new polyketides furanones A and B have been isolated from fermentation broth of Streptomyces CNQ766, found in the marine sediments displayed weak in vitro cytotoxicity against macrophages and splenocyte T-cells (Cho et al. 2006) . 

One of the major challenges faced by developing tropical countries are infectious diseases that is one of the foremost causes of death. About 335 infectious diseases were reported between 1940 to 2004 . The prominent new discovery of effective bioactive compounds from marine environment has started countering the burden of infectious disease. Abdelmohsen et al. (2010) reported 90 actinomycetes from 11 different species with anti-infective activities against clinically potential organisms such as Gram-negative (Escherichia coli, Pseudomonas aeruginosa), Gram-positive (E. faecalis, S. aureus) bacteria, human parasites (Leishmania major, Trypanosoma brucei), and fungi (C. albicans). Globally, the parasitic disease is one of the major health problems to humans, and it is responsible for one million deaths every year and it is almost close to the number of deaths caused by AIDS (Antoszczak et al. 2019; Bhatti et al. 2016) . The tropical disease caused by parasitic protozoa Leishmania, the species are Leishmania major, L. amazonensis, Leishmania aethiopica, L. tropica, Leishmania mexicana, Leishmania braziliensis, Leishmania donovani, and Leishmania Mexicana. Pimentel-Elardo et al. (2010) obtained secondary metabolites form marine sponge associated Streptomyces sp. that showed antiparasitic activities against T. brucei (staurosporine IC500.022 μM; valinomycin IC500.0032 μM; butenolide IC5031.77 μM) and L. major (staurosporine IC505.30 μM; valinomycin IC50 < 0.11 μM;).

Malaria remains one of the devastating infectious diseases globally caused by protozoan parasites of the Plasmodium genus, and its species include Plasmodium vivax, Plasmodium falciparum, Plasmodium ovale, Plasmodium malariae, and Plasmodium knowlesi that are together responsible for two million deaths with 300 million clinical cases annually. The global prevalence evidently showed that P. falciparum causes higher mortality rates compared to other species of Plasmodium (World Health Organisation 2014). The potential peptide from Streptomyces sp. LK3 (JF710608) was isolated from a Nicobar marine sediment sample that exhibited antiplasmodial activity with IC50: 25.78 mg/ml (Karthik et al. 2014) . Marinacarbolines (A À D) compounds are produced by Marinactinospora thermotolerans SCSIO 00652 which belongs to Nocardiopsacea family, exhibited antiplasmodial activity against Plasmodium falciparum with IC50 values ranging from 1.92 to 36.03 μM (Huang et al. 2011) . Marine actinobacteria Streptomyces nitrosporeus derived compound benzastatin exhibits antiviral activity against simplex virus type 1 (HSV-1), Vesicular stomatitis virus (VSV), Herpes simplex virus type 2 (HSV-2) with EC50 values of 1.92, 1.99, and 0.53 μg/mL (Lee et al. 2007 ).

Antioxidant compounds retard or prevent the oxidation of lipid. The marine isolate Nocardiopsis alba produced (Z)-1-((1-hydroxypenta-2,4-dien1-yl)oxy) anthracene-9,10-dione compound showed significant in vitro antioxidant capacity (Janardhan et al. 2014) . The Streptomyces VITSVK5 spp. was isolated by marine sediment at the Marakkanam coast in the Bay of Bengal, India, with a compound 5-(2,4-dimethylbenzyl)pyrrolidin-2-one (DMBPO), which exhibited significant antioxidant activity (50.10% at 5 μg/ml DMBPO) (Saurav and Kannabiran 2012) . Secondary metabolites, Dermacozines A-G (phenazine compounds) were obtained from Dermacoccus, which shows significant antioxidant properties (Pathom-Aree et al. 2006) . Angiogenesis is an essential step for the formation of new blood vessels from pre-existing vessels and it is a vital step for tumor cell proliferation (Risau 1997) . Streptomyces sp. isolated from the deep-sea sediment at Ayu Trough exhibit Streptopyrrolidine compounds with significant anti-angiogenesis activity (Shin et al. 2008 ). The compound Cyclo-(L-Pro-L-Met) was isolated from fermentation broth of a marine-derived actinomycete Nocardiopsis sp. 03 N67 showed anti-angiogenesis activity against human umbilical vein endothelial cells (HUVECs) (Shin et al. 2010 ).

Polysaccharides are high molecular weight polymers that are vital material for synthesizing microbial and plant cell walls, and they can be produced as both intracellular or extracellular polysaccharides (EPSs) during extreme environmental conditions. These natural polysaccharides have an exceptional physical characteristic that has extensive applications in the pharmaceutical field. Okutani (1984 Okutani ( , 1992 reported polysaccharides from Vibrio and Pseudomonas with antitumor, antiviral, and immunostimulant activities. A. infernus produced exopolysaccharide displaying anticoagulant property (Senni et al. 2011 ).

Biosurfactants or biological surfactants are microbial compounds with a wide range of structural variety (fatty acids, glycolipids, lipopeptides, phospholipids and neutral lipids, polysaccharide-protein complexes) produced by bacteria, yeast, and fungi (Mnif and Ghribi 2015) . Initially, biosurfactants are used in pollution remediation and some surface-active compounds are used as anti-adhesive agents against several pathogens, anti-biofilm against human multi-drug resistant pathogens, antibacterial, antifungal, antiviral, and anti-cancer activities (Singh and Cameotra 2004) .

The microbial origin naturally occurring biopolymers are produced by variety of microorganisms, most of them are of bacterial sourced biopolymers. Bacterial poly hydroxyalkanoates (PHAs) are polyesters synthesized by a wide variety of 300 Gram-positive and Gram-negative species as a carbon/energy storage material (Rehm 2003) . Due to its microbial origin, PHB is gaining more interest in medical applications. The unique properties of these polymers are utilized as drug carriers, biocontrol agents, antibacterials, tissue engineering, biodegradable implants, anticancer agents, and also as memory enhancers (Ray and Kalia 2017).

Marine fungi are rich in diversity of species, phylogenetic distribution and natural products (NPs) whereas in recent years extensive research has provided thorough data about marine resources (Richards et al. 2012; Imhoff 2016; Rämä et al. 2016; Taylor and Cunliffe 2016) . The diverse physical and chemical growth conditions of fungi are the prime reason for the production of novel drugs whereas certain marine fungal metabolic pathways are entirely distinct from terrestrial fungi (Kijjoa and Sawangwong 2004; Abdel-Lateff 2008) . Marine Fungai are a potential producer of secondary metabolites like peptides, alkaloids, terpenes, and mixed biosynthesis compounds. Two new indole alkaloids, (2-3, 3-dimethylprop-1-ene)epicostaclavine and (2-3, 3-dimethylprop-1-ene)-costaclavine, are known compounds of costaclavine, fumgaclavine with antibacterial activity obtained from Aspergillus fumigates (Kossuga et al. 2012) .

Several marine fungi such as Trimmatostroma salinum, Phaeotheca triangularis, Aureobasidium pullulans, Hortaea werneckii, and Cryptococcus liquefaciens produce photo-protective compounds (mycosporines). These compounds absorb UV in the range of 310-320 nm (Kogej et al. 2006) . Zopfiellamide A is a pyrrolidinone derivative; it was obtained from marine fungi Zopfiella latipes, which inhibits the growth of Gram-negative Acinetobacter calcoaceticus and Gram-positive Bacillus subtilis, Bacillus brevis, Corynebacterium insidiosum, B. licheniformis, Micrococcus luteus, Corynebacterium insidiosum, Arthrobacter citreus, Mycobacterium phlei, and Streptomyces sp. (Daferner et al. 2002) . Marine fungal antiviral compounds such as phomasetin, equisetin, and integric acid showed significant anti-HIV activities based on bioassay experiments, and Sansalvamide A compound obtained from Fusarium sp. was found against pathogenic poxvirus Molluscum contagiosum (MCV) (IC50 ¼ 124 lM) (Hwang et al. 1999 ).

This chapter provides firsthand information of marine microbial products and its marine genetic resources of commercial interest. The marine microbes possess potentially untapped resources, and if utilized properly they will lead to the discovery of novel compounds that can revolutionize the pharmaceutical industry. In recent years, a number of patents and scientific publications have demonstrated the importance of marine genetic resources to the scientific community. The remarkable new methodologies of underwater exploration, bioassays, recent technology in cultivation of marine microorganisms combined with proteomics, genomics, DNA shuffling, combinatorial chemistry, bioinformatics, and DNA shuffling are used to rapidly screen the bioactive compounds from marine microbes. Marine microbes can produce chemically unique secondary metabolites, will have greatest impact on marine natural products (MNP), and will eventually lead to revealing unexplored pharmaceutical significant bioactive compounds. As a result of improved methodologies in marine microbes and bioactive metabolites isolation has led to successful pipelines in pharmaceutical fields, Carrol et al. (2019) clearly elucidated that in last 10 years there is about 41% jump in discoveries of MNP was observed.

Chaetominedione, a new tyrosine kinase inhibitor isolated from the algicolous marine fungus Chaetomium sp

Dermacozines, a new phenazine family from deep-sea dermacocci isolated from a Mariana Trench sediment

Isolation, phylogenetic analysis and anti-infective activity screen-ing of marine spongeassociated actinomycetes

A new indol derivative from the red alga Chondra atropurpurea. Isolation, structure determination, and anthelmintic activity

Tauramamide, a lipopeptide antibiotic produced in culture by Brevibacillus laterosporus isolated from a marine habitat: structure elucidation and synthesis

Marine Streptomyces as a novel source of bioactive substances

Ess-ramycin: a first triazolopyrimidine antibiotic isolated from nature

Novel bioactive metabolites from a marine derived bacterium Nocardia sp. ALAA

New antibacterial xanthone from the marine sponge-derived Micrococcus sp. EG45

Production of a new thiopeptide antibiotic, TP-1161, by a marine Nocardiopsis species

Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinispora

Developing a new resource for drug discovery: marine actinomycete bacteria

Cycloeudesmol, an antibiotic cyclopropane conatinnin sequiterpene from the marine alga, Chondriaoppositiclada Dawson

Kainic acid selectivelystimulates the release of endogenous excitatory acidic amino acids

Proximicin A, B and C, novel aminofuran antibiotic and anticancer compounds isolated from marine strains of the actinomycete Verrucosispora

Structures of dictyodial and dictyolactone, unusual marine diterpenoids

Thiasporines A-C, thiazine and thiazole derivatives from a marinederived Actinomycetospora chlora

Antiplasmin inhibitor. V. Structures of novel dimeric eckols isolated from the brown alga Ecklonia kurome Okamura

Laurepinnacin and isolaurepinnacin: new acetylenic cyclic ethers from the marine alga Laurencia pinnata Yamada

A pentahalogenated monoterepene from the red alga Portieria hornemannii produced a novel cytotoxicity profile against a diverse panel of human tumor celllin

A novel anticancer and antifungus phenazine derivative from a marine actinomycete BM-17

Lessons from the past and charting the future of marine natural products drug discovery and chemical biology

Chemotherapy-induced resistance by ATP-binding cassette transporter genes

Characterization of antifungal chitinase from marine Streptomyces sp., DA11 associated with South China Sea sponge Craniellaaustraliensis

Mansouramycins AÀ D, cytotoxic isoquinolinequinones from a marine Streptomycete

Structures of new cytotoxic antibiotics, piericidins C 7 and C 8

Albidopyrone, a new α-pyrone-containing metabolite from marine-derived Streptomyces sp. NTK 227⋆

Caboxamycin, a new antibiotic of the benzoxazole family produced by the deep-sea strain Streptomyces sp. NTK 937

Caboxamycin, a new antibiotic of the benzoxazole family produced by the deep-sea strain Streptomyces sp NTK 937& ast

Antimalarial β-carboline and indolactam alkaloids from Marinactinospora thermotolerans, a deep sea isolate

Anti-MRSA and anti-TB metabolites from marine-derived Verrucosispora sp. MS100047

The marinopyrroles, antibiotics of an unprecedented structure class from a marine Streptomyces sp

Mechanism of inhibition of a poxvirus topoisomerase by the marine natural product sansalvamide A

Natural products from marine fungi -still an underrepresented resource

Tichocarpols A and B, two novel phenylpropanoids with feeding-deterrent activity from the red alga Tichocarpus crinitus

Komodoquinone A, a novel neuritogenic anthracycline, from marine Streptomyces sp. KS3

Production of bioactive compounds by actinomycetes and their antioxidant properties

Species-specific secondary metabolite production in marine actinomycetes of the genus Salinispora

Streptokordin, a new cytotoxic compound of the methylpyridine class from a marine-derived Streptomyces sp. KORDI-3238

Lobophorins A and B, new anti-inflammatory macrolides produced by a tropical marine bacterium

Antibiofilm activity of an exopolysaccharide from marine bacterium Vibrio sp. QY101

Insights into the evolution of macrolactam biosynthesis through cloning and comparative analysis of the biosynthetic gene cluster for a novel macrocyclic lactam, ML-449

Global trendsin emerging infectious diseases

Mechercharmycins A and B, cytotoxic substances from marine-derived Thermo actinomyces sp. YM3-251

Protease inhibitors from marine actinobacteria as a potential source for antimalarial compound

New hydroxamate metabolite, MBJ-0003, from Micromonospora sp. 29867

Protective effect of Amphiroa dilatata on ROS induced oxidative damage and MMP expressions in HT1080 cells

Drugs and cosmetics from the sea

Biological activities and potential health benefits of fucoxanthin derived from marine brown algae

Nocapyrones: α-and γ-Pyrones from a Marine-Derived Nocardiopsis sp

Diketopiperazines, inhibitors of sterol O-acyltransferase, produced by a marine-derived Nocardiopsis sp

Halitunal, an unusual diterpene Aldehyde from the marine alga Halimeda tuna

Mycosporines in extremophilic fungi-novel complementary osmolytes?

Evaluating methods for the isolation of marine-derived fungal strains and production of bioactive secondary metabolites

Seaweed resistance to microbial attack: a targeted chemical defense against marine fungi

Discovery of novel metabolites from marine actinomycetes

Marine genetic resources: a review of scientific and commercial interest

Antidiabetic activities of fucosterol from Pelvetia siliquosa

Differential antiviral activity of benzastatin C and its dechlorinated derivative from Streptomyces nitrosporeus

Chinikomycins A and B: isolation, structure elucidation, and biological activity of novel antibiotics from a marine Streptomyces sp. isolate M045, 1

Four butenolides are novel cytotoxic compounds isolated from the marine-derived bacterium, Streptoverticillium luteoverticillatum 11014

Glaciapyrroles A, B, and C, pyrrolosesquiterpenes from a Streptomyces sp. isolated from an Alaskan marine sediment

antibacterial 4-oxazolidinones from a marine actinomycete isolated from a Guam marine sediment

Isolation of biosurfactant-producing marine bacteria and characteristics of selected biosurfactant

Marine actinobacteria: an important source of bioactive natural products

Pharmaceutically active secondary metabolites of marine actinobacteria

Himalomycin A and B: isolation and structure elucidation of new fridamycin type antibiotics from a marine Streptomyces isolate

Anti-cancer and antibacterial trioxacarcins with high anti-malaria activity from a marine streptomycete and their absolute stereochemistry

Marine pharmacology in 2007-8: marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action

Lynamicins AÀ E, chlorinated bisindole pyrrole antibiotics from a novel marine Actinomycete

Piperazimycins: cytotoxic hexadepsipeptides from a marine-derived bacterium of the genus Streptomyces

Aureoverticillactam, a novel 22-atom macrocyclic lactam from the marine actinomycete Streptomyces aureoverticillatus

Exploring multi potential uses of marine bacteria; an integrated approach for PHB production, PAHs and polyethylene biodegradation

Review lipopeptides biosurfactants: mean classes and new insights for industrial, biomedical, and environmental applications

Salinamides, antiinflammatory depsipeptides from a marine Streptomycete

Sulfated polysaccharides as bioactive agents from marine algae

Salinipyrones and pacificanones, mixed-precursor polyketides from the marine actinomycete Salinispora pacifica

Sulphoquinovosyl diacylglycerol, KM043, a new potent inhibitor of eukaryotic DNA polymerases and HIVreverse transcriptase type from a marine red alga Gigartina tenella

Marine microorganisms as a source of bioactive agents

Antitumor and immunostimulant activities of polysaccharides produced by a marine bacterium of the genus Vibrio

Antiviral activities of sulfated derivatives of a fucosamine-containing polysaccharide of marine bacterial origin

Ascosalipyrrolidinone A, an antimicrobial alkaloid, from the obligate marine fungus Ascochyta salicorniae

Dermacoccus barathri sp. nov. and Dermacoccus profundi sp. nov., novel actinomycetes isolated from deepsea mud of the Mariana Trench

Antiviral activity of diterpenes isolated from the Brazilian marine alga Dictyota menstrualis against human immunodeficiency virus type 1 (HIV-1)

Antiparasitic compounds from Streptomyces sp. strains isolated from Mediterranean sponges

Marine actinomycetes: a new source of compounds against the human malaria parasite

Capisterones A and B from the tropical green Alga Penicillus capitatus: unexpected anti-fungal defenses targeting the marine pathogen Lindra thallasiae

Bio monitoring of heavy metal availability in the marine environment

Fungi sailing the Arctic Ocean: speciose communities in North Atlantic driftwood as revealed by highthroughput amplicon sequencing

An overview of the marine natural products in clinical trials and on the market

Anti-cancer property of sponge associated actinomycetes along Palk Strait

Biomedical applications of polyhydroxyalkanoates

Polyester synthases: natural catalysts for plastics

Marine fungi: their ecology and molecular diversity

Marine nematodes: tetrahydrofuran from a southern Australian brown alga

Abyssomicins, inhibitors of the paraaminobenzoic acid pathway produced by the marine Verrucosispora strain AB-18-032

Mechanisms of angiogenesis

Pseudomonas marincola sp. nov., isolated from marine environments

Thiocoraline, a new depsipeptide with antitumor activity produced by a marine Micromonospora

Microalgae in aquaculture: a review with special references to nutritional value and fish dietetics

Proximicins A, B,and C-antitumor furan analogues of netropsin from the marine actinomycete Verrucosispora induce upregulation of p53 and the cyclin kinase inhibitor p21

Biosynthesis and structures of cyclomarins and cyclomarazines, prenylated cyclic peptides of marine actinobacterial origin

Isolation and structure determination of an antimicrobial ester from a marine sediment-derived bacterium

Marine polysaccharides: a source of bioactive molecules for cell therapy and tissue engineering

Streptopyrrolidine, an angiogenesis inhibitor from a marine-derived Streptomyces sp. KORDI-3973

An angiogenesis inhibitor isolated from a marine-derived actinomycete, Nocardiopsis sp. 03N67

Potential applications of microbial surfactants in biomedical sciences

Bioactive compounds from marine actinomycetes

Novel caprolactones from a marine Streptomycete

Culturable rare actinomycetes: diversity, isolation and marine natural product discovery

Marine rare actinomycetes: a promising source of structurally diverse and unique novel natural products

New diketopiperazine derivatives with cytotoxicity from Nocardiopsis sp. YIM M13066

Potent cytotoxic metabolites from a Leptosphaeria species. Structure determination and conformational analysis

Multi-year assessment of coastal planktonic fungi reveals environmental drivers of diversity and abundance

Antimicrobial metabolites from a marine-derived actinomycete in Vietnam's East Sea

Marine ecosystems

The isolation, purification and biological activity of a novel antibacterial compound produced by Pseudomonas stutzeri

A patchwork of Streptomyces species isolated from potato common scablesions in North America

Actinomycetes in North Sea and Atlantic Ocean sediments

Saliniketals A and B, bicyclic polyketides from the marine actinomycete Salinispora arenicola

Antimicrobial resistance: 2014 global report on surveillance. World Health Organization

Forazoline A: marine-derived polyketide with antifungal in vivo efficacy

Marine actinomycetes as an emerging resource for the drug development pipelines